How to Screen for Non-Adherence to Antihypertensive Therapy.

Curr Hypertens Rep 2016 Dec;18(12):89

Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review, we discuss the different methods used to assess adherence to blood-pressure-lowering medications in hypertension patients. Subjective reports such as physicians' perceptions are inaccurate, and questionnaires completed by patients tend to overreport adherence and show a low diagnostic specificity. Indirect objective methods such as pharmacy database records can be useful, but they are limited by the robustness of the recorded data. Electronic medication monitoring devices are accurate but usually track adherence to only a single medication and can be expensive. Overall, the fundamental issue with indirect objective measures is that they do not fully confirm ingestion of antihypertensive medications. Detection of antihypertensive medications in body fluids using liquid chromatography-tandem mass spectrometry is currently, in our view, the most robust and clinically useful method to assess non-adherence to blood-pressure-lowering treatment. It is particularly helpful in patients presenting with resistant, refractory or uncontrolled hypertension despite the optimal therapy. We recommend using this diagnostic strategy to detect non-adherence alongside a no-blame approach tailoring support to address the perceptions (e.g. beliefs about the illness and treatment) and practicalities (e.g. capability and resources) influencing motivation and ability to adhere.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11906-016-0697-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124437PMC
December 2016
16 Reads

Publication Analysis

Top Keywords

antihypertensive medications
8
indirect objective
8
alongside no-blame
4
single medication
4
adherence single
4
track adherence
4
devices accurate
4
accurate track
4
medication expensive
4
expensive fundamental
4
objective measures
4
strategy detect
4
detect non-adherence
4
issue indirect
4
no-blame approach
4
fundamental issue
4
non-adherence alongside
4
monitoring devices
4
records limited
4
support address
4

References

(Supplied by CrossRef)
Article in Lancet
PM Kearney et al.
Lancet 2005
Article in Eur J Prev Cardiol
K Kotseva et al.
Eur J Prev Cardiol 2016
Article in J Clin Hypertens
WJ Elliott et al.
J Clin Hypertens 2009
Article in Am Heart J
HB Bosworth et al.
Am Heart J 2011
Article in Am J Hypertens
M Burnier et al.
Am J Hypertens 2006
Article in Eur Heart J
K Kolandaivelu et al.
Eur Heart J 2014
Article in Eur Heart J
R Chowdhury et al.
Eur Heart J 2013
Article in J Gen Intern Med
BG Bokhour et al.
J Gen Intern Med 2006
Article in BMJ Open
W Clyne et al.
BMJ Open 2016
Article in Hypertension
DA Calhoun et al.
Hypertension 2014
Article in Circulation
DA Calhoun et al.
Circulation 2008

Similar Publications